Imperative Care wins FDA clearance for Zoom stroke treatment

Imperative Care announced today that it has secured FDA 510(k) clearance for its Zoom comprehensive stroke thrombectomy system.

According to Campbell, California–based Imperative Care, the Zoom system is the first such system to include large-bore .088-in. catheters indicated for both access and aspiration when used with one of the company’s Zoom catheters.

The FDA clearance expands Imperative Care’s present portfolio of .035 in. to .071 in. aspiration catheters to now include the Zoom .088 in. catheters for use with the Zoom system. The new .088 in. catheters are Zoom 88, Zoom 88 Support and TracStar.

“At Imperative Care, we are focused on developing a patient-centric and well-studied comprehensive stroke system for physicians to best care for their patients based on their specific needs and anatomy,” Ariel Sutton, EVP and GM of Imperative Care’s Stroke business, said in a news release.

Sign up for Blog Updates